David C. Hohn, MD, President Emeritus of RPCI and Vice Chairman of the New York State Stem Cell Board, joins colleagues Andrei V. Gudkov, PhD, DSc, and Gary J. Smith, PhD, in a conversation about what stem cells are and how they fit into research on cancer treatment and prevention.

Richard Matner, PhD, MBA, former Director of Technology and Commercial Development, and Ravindra Pandey, Professor and Distinguished Member, Department of Cellular Stress Biology, highlight a revolutionary technology that originated out of RPCI, with an update on commercialization efforts.